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A B ST R A C T  
 
Testicular tumors of the adrenogenital syndrome (TTAGS) are a rare disease, with a benign curse. We present 
the case of a 12-year-old patient with congenital adrenal hyperplasia (CAH), precocious puberty and bilateral 
testicular masses. Hormonal control had been adequate. Incidental finding of bilateral testicular masses, with 
negative testicular tumoral biomarkers. The patient underwent right testicular sparing surgery, finding an intra-
parenchymal nodular mass. Pathological study showed a TTAGS, positive for CD99, Melan A, inhibin and 
synaptophysin markers. Conservative management was decided. 
Key Words: Testicular tumors; adrenogenital syndrome; congenital adrenal hyperplasia; leydig cells tumor.  
                                                                                          Copyright © 2018 pediatricurologycasereports.com                                 
Corresponding Author: Ana Ortiz Zableh  
Pontificia Universidad Javeriana. Bogotá D.C.- 
Colombia 
E-mail: aortizz.92@gmail.com 
Accepted for publication: 24 January 2018 
 
Introduction 
Testicular tumors of adrenogenital syndrome 
(TTAGS) are an entity presented in boys with 
congenital adrenal hyperplasia (CAH) [1,2]. 
These tumors have a benign curse, are usually 
bilateral, localized near the testicular 
mediastinum [3–5]. Due to their location, these 
tumors can lead to mechanical obstruction of 
the seminiferous tubules. A comprehensive 
clinical assessment is needed to identify 
TTAGS in patients with CAH. The differential 
diagnosis with Leydig Cell Tumor (LCT) is the 
principal objective in the evaluation of these 
patients, due to the fact that their management 
is different [1]. Both medical and surgical 
treatments are available for preventing gonadal 
dysfunction [1,2]. 
 
Case report 
12-year-old boy diagnosed with CAH at the 
age of three, due to precocious puberty; he was 
referred to the pediatric urology service 
because of the incidental finding of bilateral 
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testicular masses.  He was being managed with 
hydrocortisone (25 mg/day) with adequate 
hormonal control: 17-Hydroxyprogesterone, 
dehydroepiandrosterone, androstenedione and 
testosterone levels were between normal 
ranges.  
Physical examination showed a Tanner Scale 
of A3, P4, G3. The abdomen was soft, non-
tender, with no masses. The penis was normal. 
The right testicle had a volume of 6-8 ml and 
the left testicle of 8-10 ml. An irregular and 
hard mass was felt towards the posterior 
aspects of both testicles [Fig. 1]. 
 
 
Fig. 1. Physical examination. 
 
Testicular tumor markers were negative. 
Testicular ultrasonography showed testicles of 
normal size and position, with altered bilateral 
echogenicity due to a mediastinal hypo 
echogenic lesion, which occupied 30% of each 
of the testicles, with micro calcifications [Fig. 
2].  
 
 
Fig. 2. Testicular ultrasonography: bilateral 
intraparenchimatose hipoechogenic lesion. 
 
The patient underwent right testicular sparing 
surgery, finding a nodular intraparenchimatose 
mass towards the posterior aspect of the 
testicle, with direct contact to the rete testis, of 
approximately 3.5 x 1 cm. There were no 
alterations in the epididymis [Fig. 3A-F]. A 
complete resection of the mass was 
accomplished, and it was sent to pathology.  
 
 
Fig. 3. Right testicular sparing surgery. A) Right 
testicle with usual aspect, with a mass felt in the 
posterior aspect. B/C) Opening of the tunica 
vaginalis and exposition of the nodular mass. D) 
Complete resection of the mass, no lesions in the 
testicular vessels. E) Surgical specimen. F) Closure 
of the tunica vaginalis, vital testicle. 
 
Histopathological studies reported the mass 
initially as a LCT, and a new pathology study 
was requested; immunohistochemistry studies 
were positive for CD99, Melan A, Inhibin and 
synaptophysin markers [Fig. 4A-C, 5A,B].  
 
 
Fig. 4. Hematoxylin and Eosin Staining (H & E): 
A) testicular parenchyma replaced with cords cells 
with eosinophilic cytoplasm, without Reinke 
crystals, separated by cord cells. B) Trichrome 
staining enhancing the collagen tracts separating 
the cord cells. C) Testicular parenchyma in contrast 
with the cords of the Leydig Cells. 
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Fig. 5. Immunohistochemistry. A) Positive 
synaptophysin in the cords of the Leydig Cells. B) 
Positive inhibin in the Leydig Cells. 
 
Discussion 
During the fifth week of gestation, the adrenal 
glands develop closely to the gonads, and their 
separation does not occur until the adrenal 
glands are prominent. Before this stage, the 
cortical adrenal tissue can be attached to the 
gonads. This aberrant adrenal tissue can 
descend next to the testicles, so ectopic adrenal 
tissue can be found in the testicles of normal 
subjects [6] [Fig. 6]. Testicular tumors formed 
from the remains of adrenal tissue have been 
observed in cases with elevation of ACTH, as 
seen in Nelson’s syndrome, Cushing’s disease 
and Addison’s disease, and in up to 27 to 47% 
of male patients with CAH [6].  
 
 
Fig. 5. Paratesticular ectopic adrenal tissue (black 
arrow). 
 
The adrenogenital syndrome includes a group 
of recessive autosomal defects in the adrenal 
steroidogenesis [7]. The incidence is not 
known, but has been reported from 8,2 to 94-
100% of the patients with CAH [2,8]. It was 
first described by Lawson Wilkins [5] and 
identified as testicular adrenal rest tumors 
resulting from 21-hydroxylase (CYP21A2) 
deficiency [4]. 
TTAGS are hormone dependent tumors, and 
their etiology has not yet been confirmed [2,5]. 
There are few hypotheses now days, and it is 
believed that their pathogenesis is the result of 
hyperplasic increase of adrenal rest, that are 
trapped inside the gonads in the fetal process 
of the interstitial testicular cells, or cells 
derived from pluripotent cells of the testicular 
stroma, that are stimulated by elevated levels 
of ACTH [2,7,9]. One hypothesis that has been 
justified by studies shows that testicular 
tumors formed from adrenal remains produce 
and express specific adrenal molecules, 
confirming its great resemblance with this 
tissue. These remains also have been described 
in the celiac plexus, the broad ligament and 
ovaries [4]. Around 27 to 94% of patients with 
CAH have some form of testicular lesions. In 
men with CAH, adrenal remains can produce 
infertility in up to 30% of the patients [4], and 
oligospermia and azoospermia has been seen 
in more than 40% of patients [2]. One recent 
study determined that TARTS have multiple 
steroidogenic properties, including not only 
the expression of adrenal cortex, but Leydig 
cell markers as well; they concluded that these 
tumors might have a more totipotent 
embryonic cell type [9].  
Traditionally, standard treatment of 
unrecognized tumors of adrenogenital 
syndrome, steroid resistant tumors and 
misdiagnosed LCT is orchiectomy. Recently, 
other studies have demonstrated the viability 
of testicular sparing surgery as an alternative to 
the traditional orchiectomy in benign testicular 
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tumors, as the most important consideration in 
these patients is fertility [2,7]. Our patient was 
provided with the alternative of a conservative 
treatment approach, with testicular sparing 
surgery, that allowed the resection of the 
described lesion with free tumor resection 
margins, and the conservation of the testicular 
function. A surgical specimen appropriate for 
immune histopathological studies was 
achieved, so that we could pin down our 
diagnosis and adjust the treatment schemes.  
These tumors present as a diagnosis problem 
and have to be differentiated from other tumors 
that might be found in the testicles, especially 
LCT [5,6], such as in the case presented in this 
article. LCT are neoplasic lesions that show 
transformation of the specialized testicular 
stroma (Leydig Cells), and count for 1-3% of 
all testicular tumors; 3% are bilateral and up to 
10% show malignancy and can affect any 
group of age [4]. This is why it is so important 
to use all the available diagnostic options, so 
that an adequate evaluation of the surgical 
pathology is made [4]. 
TTAGS are bilateral in approximately 83% of 
cases, they are a benign sequel from an 
endocrine disease, and appear especially in 
younger patients [6], between 20 to 40 years 
old [2,6]. In macroscopic exams TTAGS are 
big multiple masses with “dark green” nodules, 
unlike LCT which are small, solid and yellow 
masses [1,2]. A study of TTAGS by Ashely 
and co [1], has provided useful microscopic 
characteristics. In this study, H & E staining 
revealed extensive fibrosis with adipose 
metaplasia in 56 to 78% of the cases of 
TTAGS, unlike LCT, were 0% showed these 
characteristics. The presence of lymphoid 
aggregates (67% and 8%), nuclear 
pleomorphism of 3+ or 4+ grade (56% and 8%) 
and prominent lipochrome pigment (67% and 
15%), were useful characteristics, seen 
predominantly in TTAGS. In contrast, there 
was a complete absence of mitotic figures in 
TTAGS, while in LCT they are found in 69% 
of the cases. Reinke’s crystalloids are present 
in only 40% of LCT; therefore, their absence 
does not exclude LCT. In 
immunohistochemistry stains, reactivity with 
synaptophysin was observed in 88% of 
TTAGS, while in just 8% of LCT. In contrast, 
inhibin and cytokeratins are equally positive. 
Needle guided biopsy on its own is not the 
ideal technique to differentiate TTAGS from 
LCT [4].  
The suppression of the elevated ACTH with 
glucocorticoid replacement treatment 
decreases the systemic adrenal hyperplasia and 
causes a fast regression of the adrenal tumor 
size in 75% of cases [4,7]. Bricaire and Luton 
reported in 1966 one case of negative response 
the glucocorticoid therapy, suggesting that the 
steroid dose required to cause a regression of 
the tumor, was considerably greater than the 
necessary to correct the biochemical levels of 
17-cetosteroids [7]. As we exposed with our 
patient, who had adequate levels of hormonal 
control, a regression of the tumors was not 
feasible despite an increase in the treatment 
dose. It has been postulated that the persistence 
of the tumor despite glucocorticoid treatment, 
suggest that the excess of ACTH it is not the 
only cause of their presence [6]. Nevertheless, 
benefits from the medical treatment have been 
described in case reports with different results, 
depending in the patient selection, the type of 
CAH and the treatment election [3]. On the 
other hand, a study demonstrated that to 
preserve the testicles, surgery has not shown 
any benefits over the gonadal function in 
patients with long evolution of bilateral 
adrenogenital syndrome. This can be explained 
because of the irreversible damage of the 
residual testicular tissue, for example as a 
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result of the chronic obstruction of the 
seminiferous tubules [2,3]. This leaves the 
conservative management with steroid 
replacement as an excellent treatment option. 
 
Conclusions 
TTAGS are a different entity from usual 
testicular tumors, they can be easily 
misdiagnosed as LCT, but an adequate patient 
history, a detailed hormonal evaluation, and in 
selected cases histopathology studies that 
include specific stain and markers, can confirm 
the diagnosis, and lead to a proper conservative 
treatment, preventing the associated gonadal 
dysfunction.  
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